Vitaly Margulis, MD, discusses key disease characteristics and patient factors to consider when selecting between IO/IO vs IO/TKI treatment combinations for the management of patients with renal cell carcinoma.
The building is a collaboration between UT Dallas and UT Southwestern that will house 3D-printing rooms, researchers from both schools and a metal fabrication plant.